An overview of Medicare Advantage from Chartis, top PBMs by market share, hospital economic updates, and more healthcare news from the week
{beacon}
{ad_logo_primary}
{if hosp_dorm_120 == true}
Quick favor: Our records indicate that you aren’t opening this email. But records can be wrong. Please click here if you’d like to remain subscribed to Hospitalogy.
{/if}
Happy Wednesday, Hospitalogists!
Today's is your usual mid-week check-in to everything happening across healthcare. Enjoy!
Chartis Medicare Advantage Overview is a Must-Read
Resource of the week goes to Chartis’ overview of MA enrollment in 2025 including trended analysis from prior years. Highlights from the report include:
Decelerating growth and penetration of MA plans versus traditional Medicare (3.9% in 2024 vs. 7.0% in 2023). That being said, it’s still a growing market, and there remain plenty of opportunities.
SNP growth displayed a similar decelerating growth trend, but still grew over 10% in 2025. Still, notably, 50% of new MA enrollees selected SNPs, particularly Chronic Condition SNPs. UnitedHealth Group holds a 40% market share in the SNP segment.
The average senior has access to over 5,000 plans!!! But that number shrank 1.6% in 2025.
Notable market exits and reduction of benefits
Enrollment changes among for-profit’s, nonprofits, provider sponsored plans (and, side note, their continued struggle), and startup plans (with a keen eye on Zing Health, which raised $140M in September 2024 to focus on the CSNP segment specifically)
The Weekly Executive Summary
Key considerations for decision makers. Notable moves, policies, and strategies
Top PBMs Ranked: Drug Channels has been putting out some wonderful content lately around the state of the market and PBMs. To that end, per Adam Fein's analysis, CVS Health’s Caremark, Cigna’s Express Scripts, and UnitedHealth Group’s OptumRx remain the largest PBMs in the U.S. as of 2025. Look at that big loss in Caremark gobbled up by Express Scripts in 2025.
PBM Formulary Changes: The Big Three PBMs—CVS Health’s Caremark, Cigna’s Express Scripts, and UnitedHealth Group’s OptumRx—have announced formulary exclusions affecting over 400 medications for 2025.
Notable News & Moves:
Oracle Health Breach: Oracle Health experienced a data breach compromising patient data across several U.S. hospitals.
OSI Neurosurgery Merger: Orthopedic & Spine Institute Medical Centers (OSI) has announced a merger creating a new neurosurgery division.
Compassus-Providence JV: The joint venture between Compassus and Providence is gaining traction despite ongoing regulatory scrutiny.
Wells Fargo ERISA Dismissal: A judge has dismissed a lawsuit alleging Wells Fargo breached ERISA obligations related to prescription drug costs.
JPMorgan Benefits Lawsuit: JPMorgan Chase employees have filed a class-action lawsuit, alleging mismanagement of health benefits.
Morgan Health ICHRA Investment: JPMorgan Chase’s Morgan Health has invested in Venteur, a health technology platform focused on personalized health insurance benefits.
Hospital Economic Indicators:
Hospital Margin Improvement: Fitch Ratings reports margin improvements for U.S. not-for-profit hospitals in early 2025, though financial pressures continue.
Strategic Healthcare Finance: Kaufman Hall’s Ken Swanson advises healthcare leaders to prioritize long-term financial strategies amid market pressures.
Healthcare Volume Benchmarks: Strata Decision Technology has released monthly benchmarks showing healthcare service volume trends.
Microhospital Expansion: CommonSpirit Health, ChristianaCare, and WellSpan Health are among health systems building microhospitals to deliver acute care in smaller community settings.
DOJ Anticompetition Taskforce: The U.S. Justice Department has launched a task force targeting anticompetitive regulations, aiming to eliminate rules harming competition across industries.
HHS Job Cuts: HHS Secretary Robert F. Kennedy Jr. announced significant job cuts and restructuring at the agency. In a fact sheet, HHS disclosed a cut of 10,000 FTEs across the FDA (3,500), CDC (2,400), NIH (1,200) and CMS (300). Furthermore, HHS will consolidate 28 divisions to 15, and 10 regional offices to 5 in a major centralizing move of governmental healthcare resources. Healthcare centralization seems to be a big theme so far with the new administration.
NIH Funding Cuts: Academic medical centers warn that cuts to NIH funding jeopardize critical healthcare research. These 20 medical schools lead NIH funding.
MedPAC Congressional Report: MedPAC’s March 2025 report outlines recommendations for Medicare payment policy improvements.
Recommendations, summarized:
IPPS and OPPS: update by amount specified in current law, plus 1%; redistribute existing disproportionate share payments to better distribute funds to hospitals that need funds the most.
MPFS: replace current updates (e.g., constant cuts) with a reimbursement method tied to the Medicare Economic Index (e.g., healthcare cost inflation), minus one percentage point
Dialysis: maintain current payment updates as per current law
SNFs: cut base reimbursement by 3%
Home Health: cut base reimbursement by 7% (!!!)
IRFs: cut base reimbursement by 7% (!!!)
Hospice: no increase to base reimbursement recommended (i.e,. 0%)
IPF: structural changes to reimbursement (eliminating the 190 day lifetime limit on covered days in freestanding IPFs)
Confirmations:
Dr. Oz CMS Confirmation: Dr. Mehmet Oz has been confirmed by the Senate as administrator of the Centers for Medicare and Medicaid Services (CMS).
NIH Confirmation (Bhattacharya): Dr. Jay Bhattacharya has been confirmed by the Senate as NIH director.
FDA Confirmation (Makary): Dr. Marty Makary has been confirmed by the Senate as the new FDA commissioner.
Medicaid Cuts & Updates:
Medicaid Provider Payments Debate: Provider taxes and state-directed payments are facing increased scrutiny amid Medicaid budget cut debates.
Medicaid, SNAP Cuts Impact: Commonwealth Fund reports that proposed cuts to Medicaid and SNAP could trigger significant job losses and reductions in state revenue.
GLP-1 Spending Surge: Evernorth reports spending on GLP-1 weight-loss medications is surging faster than other specialty pharmacy categories.
Lilly Lawsuit: Eli Lilly has sued two pharmacies that compound drugs, alleging infringement related to unauthorized copies of its popular weight-loss medications, Mounjaro and Zepbound.
‘With agentic AI in Causaly Discover, life sciences teams can access, analyze, and synthesize information across the Causaly Knowledge Graph and internal and external data sources.’
Stay tuned though - my next newsletter will be a breakdown of Baylor Scott & White after sitting down with Baylor's CEO, Pete McCanna who was very gracious to spend some time with me recently. Insights on leadership, culture, Baylor's strategy, and more coming your way.
Thanks for the read! Let me know what you thought by replying back to this email.
— Blake
{if profile.vars.rh_reflink_9}
Share Hospitalogy, Earn Rewards
Have friends who'd love Hospitalogy too? Click the link below to share Hospitalogy with your friends and earn awesome rewards!
PS: You have referred {{profile.vars.rh_totref_9}} people so far